Review



adenoviruses expressing cmv gfp  (Vector Biolabs)


Bioz Verified Symbol Vector Biolabs is a verified supplier
Bioz Manufacturer Symbol Vector Biolabs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Vector Biolabs adenoviruses expressing cmv gfp
    Adenoviruses Expressing Cmv Gfp, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 367 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/adenovirus+ad+cmv+gfp/Ad-GFP/pmc12504421-357-18-31
    Average 96 stars, based on 367 article reviews
    adenoviruses expressing cmv gfp - by Bioz Stars, 2026-08
    96/100 stars

    Images



    Similar Products

    96
    Vector Biolabs adenoviruses expressing cmv gfp
    Adenoviruses Expressing Cmv Gfp, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/adenovirus+ad+cmv+gfp/Ad-GFP/pmc12504421-357-18-31
    Average 96 stars, based on 1 article reviews
    adenoviruses expressing cmv gfp - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    Vector Biolabs adenovirus ad cmv p53 gfp vector biolabs
    Adenovirus Ad Cmv P53 Gfp Vector Biolabs, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/adenovirus+ad+cmv+gfp/Ad-p53-GFP/pm40961924-807-155-158
    Average 96 stars, based on 1 article reviews
    adenovirus ad cmv p53 gfp vector biolabs - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    Vector Biolabs adenovirus ad cmv gfp
    Adenovirus Ad Cmv Gfp, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/adenovirus+ad+cmv+gfp/Ad-GFP/pmc12490241-126-0-3
    Average 96 stars, based on 1 article reviews
    adenovirus ad cmv gfp - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    Vector Biolabs adenovirus ad cmv p53 gfp
    Adenovirus Ad Cmv P53 Gfp, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/adenovirus+ad+cmv+gfp/Ad-p53-GFP/pmc12490241-127-0-5
    Average 96 stars, based on 1 article reviews
    adenovirus ad cmv p53 gfp - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    Vector Biolabs ad cmv cre cre recombinase adenovirus co expression with gfp
    (A) Transmission electron microscopy (TEM) images of IDH non-mutant chondrosarcoma cells (n = 4) in vitro display absent glycogen granules. Organelles distinct from glycogen granules shown in magnified insets labeled as follows: M, mitochondria; L, lysosome; ER, rough endoplasmic reticulum. TEM images: 7× magnification, inset images: 70× magnification. (B) TEM images of mutant IDH chondrosarcoma cells (n = 7) display glycogen pools, asterisks denote aggregates of glycogen pools in mutant IDH cells, and arrows in magnified insets indicate glycogen pools. Glycogen appears as closely packed circular granules in mutant IDH chondrosarcoma patient cells. Images: 7× magnification, inset images: 70× magnification. (C) Glycogen quantification from pulverized patient-derived xenograft chondrosarcoma tissues display an elevation of glycogen in mutant IDH1 (n = 17) and IDH2 (n = 8) tumors compared with non-mutant tumors (n = 8). One-way ANOVA confirms significant statistical difference of glycogen levels between tumor genotypes (F(2,30) = 6.150, p = 0.0058). Tukey’s multiple comparisons test indicates that the mean values of glycogen in mutant IDH1 (p = 0.0107) and mutant IDH2 groups (p = 0.0109) were significantly higher than in non-mutant tumors. (D) PAS staining identified glycogen deposits in mutant IDH1 (n = 4) and IDH2 (n = 4) patient chondrosarcomas compared with non-mutant tumors (n = 5). PAS-D staining displays dissolution of glycogen deposits in mutant IDH tumors, thus confirming the presence of glycogen deposits. Arrows in magnified insets indicate glycogen deposits in cytoplasm of cells. Images: 40× magnification, inset images: 60× magnification. (E) Quantification of PAS-stained area (μm 2 ), normalized to total number of cells, and of PAS-D-stained area shows an elevation of glycogen deposits in mutant IDH1 (n = 4) and IDH2 (n = 4) chondrosarcomas compared with non-mutant tumors (n = 5). One-way ANOVA confirms significant statistical difference of glycogen levels between tumor genotypes (F(2,10) = 7.537, p = 0.0101). Tukey’s multiple comparisons test indicates mean values of glycogen in mutant IDH1 (p = 0.0380) and mutant IDH2 groups (p = 0.0123) were significantly higher than non-mutant tumors. (F) Glycogen deposits in Col2a1Cre; Idh1 LSL/wt E18.5 growth plates (n = 9) shown by PAS staining. Arrows in magnified insets indicate glycogen in cell cytoplasm. Glycogen deposits minimally in Col2a1Cre; Idh1 wt/wt control growth plates (n = 8). (G) Quantification of PAS-stained area (μm 2 ), normalized to total number of cells, and PAS-D-stained area (n = 8). (H) GYS1 staining is elevated in Col2a1Cre; Idh1 LSL/wt growth plates compared with Col2a1Cre; Idh1 wt/wt growth plates (n = 5). (I) Quantification of GYS1 staining from hypertrophic to resting zones (n = 5). (J) PYGL staining is unchanged in Col2a1Cre; Idh1 LSL/wt and Col2a1Cre; Idh1 wt/wt growth plates (n = 6). (K) Quantification of PYGL staining from hypertrophic to resting zones (n = 6). (L) Gene expression levels of glycogen genes are elevated upon Idh1 mutation induced by <t>adenovirus</t> Cre <t>recombinase</t> transfection (n = 3). Relative gene expression compared with adenovirus <t>GFP</t> control group was calculated and normalized to β-actin using the 2 −ΔΔCt method. One-way ANOVA with Tukey’s multiple comparisons test = p < 0.05. p value = Student’s t test p < 0.05, an asterisk (*) indicates that significant p values are shown. Means and error bars representing standard deviations are shown. Scale bars: 2 μm in white, 100 μm in black, and 10 μm in blue. Magnification: whole growth plate images: 13× magnification, inset images: 60× magnification.
    Ad Cmv Cre Cre Recombinase Adenovirus Co Expression With Gfp, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/adenovirus+ad+cmv+gfp/Ad-Cre-GFP/pmc10592452-128-0-8
    Average 96 stars, based on 1 article reviews
    ad cmv cre cre recombinase adenovirus co expression with gfp - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    90
    Obiogene Inc adenovirus ad-cmv-gfp (ad-gfp)
    (A) Transmission electron microscopy (TEM) images of IDH non-mutant chondrosarcoma cells (n = 4) in vitro display absent glycogen granules. Organelles distinct from glycogen granules shown in magnified insets labeled as follows: M, mitochondria; L, lysosome; ER, rough endoplasmic reticulum. TEM images: 7× magnification, inset images: 70× magnification. (B) TEM images of mutant IDH chondrosarcoma cells (n = 7) display glycogen pools, asterisks denote aggregates of glycogen pools in mutant IDH cells, and arrows in magnified insets indicate glycogen pools. Glycogen appears as closely packed circular granules in mutant IDH chondrosarcoma patient cells. Images: 7× magnification, inset images: 70× magnification. (C) Glycogen quantification from pulverized patient-derived xenograft chondrosarcoma tissues display an elevation of glycogen in mutant IDH1 (n = 17) and IDH2 (n = 8) tumors compared with non-mutant tumors (n = 8). One-way ANOVA confirms significant statistical difference of glycogen levels between tumor genotypes (F(2,30) = 6.150, p = 0.0058). Tukey’s multiple comparisons test indicates that the mean values of glycogen in mutant IDH1 (p = 0.0107) and mutant IDH2 groups (p = 0.0109) were significantly higher than in non-mutant tumors. (D) PAS staining identified glycogen deposits in mutant IDH1 (n = 4) and IDH2 (n = 4) patient chondrosarcomas compared with non-mutant tumors (n = 5). PAS-D staining displays dissolution of glycogen deposits in mutant IDH tumors, thus confirming the presence of glycogen deposits. Arrows in magnified insets indicate glycogen deposits in cytoplasm of cells. Images: 40× magnification, inset images: 60× magnification. (E) Quantification of PAS-stained area (μm 2 ), normalized to total number of cells, and of PAS-D-stained area shows an elevation of glycogen deposits in mutant IDH1 (n = 4) and IDH2 (n = 4) chondrosarcomas compared with non-mutant tumors (n = 5). One-way ANOVA confirms significant statistical difference of glycogen levels between tumor genotypes (F(2,10) = 7.537, p = 0.0101). Tukey’s multiple comparisons test indicates mean values of glycogen in mutant IDH1 (p = 0.0380) and mutant IDH2 groups (p = 0.0123) were significantly higher than non-mutant tumors. (F) Glycogen deposits in Col2a1Cre; Idh1 LSL/wt E18.5 growth plates (n = 9) shown by PAS staining. Arrows in magnified insets indicate glycogen in cell cytoplasm. Glycogen deposits minimally in Col2a1Cre; Idh1 wt/wt control growth plates (n = 8). (G) Quantification of PAS-stained area (μm 2 ), normalized to total number of cells, and PAS-D-stained area (n = 8). (H) GYS1 staining is elevated in Col2a1Cre; Idh1 LSL/wt growth plates compared with Col2a1Cre; Idh1 wt/wt growth plates (n = 5). (I) Quantification of GYS1 staining from hypertrophic to resting zones (n = 5). (J) PYGL staining is unchanged in Col2a1Cre; Idh1 LSL/wt and Col2a1Cre; Idh1 wt/wt growth plates (n = 6). (K) Quantification of PYGL staining from hypertrophic to resting zones (n = 6). (L) Gene expression levels of glycogen genes are elevated upon Idh1 mutation induced by <t>adenovirus</t> Cre <t>recombinase</t> transfection (n = 3). Relative gene expression compared with adenovirus <t>GFP</t> control group was calculated and normalized to β-actin using the 2 −ΔΔCt method. One-way ANOVA with Tukey’s multiple comparisons test = p < 0.05. p value = Student’s t test p < 0.05, an asterisk (*) indicates that significant p values are shown. Means and error bars representing standard deviations are shown. Scale bars: 2 μm in white, 100 μm in black, and 10 μm in blue. Magnification: whole growth plate images: 13× magnification, inset images: 60× magnification.
    Adenovirus Ad Cmv Gfp (Ad Gfp), supplied by Obiogene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/adenovirus+ad+cmv+gfp/adenovirus+ad+cmv+gfp++ad+gfp+/pm35163605-255-0-6
    Average 90 stars, based on 1 article reviews
    adenovirus ad-cmv-gfp (ad-gfp) - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    96
    Vector Biolabs cmv gfp adenovirus
    (A) Transmission electron microscopy (TEM) images of IDH non-mutant chondrosarcoma cells (n = 4) in vitro display absent glycogen granules. Organelles distinct from glycogen granules shown in magnified insets labeled as follows: M, mitochondria; L, lysosome; ER, rough endoplasmic reticulum. TEM images: 7× magnification, inset images: 70× magnification. (B) TEM images of mutant IDH chondrosarcoma cells (n = 7) display glycogen pools, asterisks denote aggregates of glycogen pools in mutant IDH cells, and arrows in magnified insets indicate glycogen pools. Glycogen appears as closely packed circular granules in mutant IDH chondrosarcoma patient cells. Images: 7× magnification, inset images: 70× magnification. (C) Glycogen quantification from pulverized patient-derived xenograft chondrosarcoma tissues display an elevation of glycogen in mutant IDH1 (n = 17) and IDH2 (n = 8) tumors compared with non-mutant tumors (n = 8). One-way ANOVA confirms significant statistical difference of glycogen levels between tumor genotypes (F(2,30) = 6.150, p = 0.0058). Tukey’s multiple comparisons test indicates that the mean values of glycogen in mutant IDH1 (p = 0.0107) and mutant IDH2 groups (p = 0.0109) were significantly higher than in non-mutant tumors. (D) PAS staining identified glycogen deposits in mutant IDH1 (n = 4) and IDH2 (n = 4) patient chondrosarcomas compared with non-mutant tumors (n = 5). PAS-D staining displays dissolution of glycogen deposits in mutant IDH tumors, thus confirming the presence of glycogen deposits. Arrows in magnified insets indicate glycogen deposits in cytoplasm of cells. Images: 40× magnification, inset images: 60× magnification. (E) Quantification of PAS-stained area (μm 2 ), normalized to total number of cells, and of PAS-D-stained area shows an elevation of glycogen deposits in mutant IDH1 (n = 4) and IDH2 (n = 4) chondrosarcomas compared with non-mutant tumors (n = 5). One-way ANOVA confirms significant statistical difference of glycogen levels between tumor genotypes (F(2,10) = 7.537, p = 0.0101). Tukey’s multiple comparisons test indicates mean values of glycogen in mutant IDH1 (p = 0.0380) and mutant IDH2 groups (p = 0.0123) were significantly higher than non-mutant tumors. (F) Glycogen deposits in Col2a1Cre; Idh1 LSL/wt E18.5 growth plates (n = 9) shown by PAS staining. Arrows in magnified insets indicate glycogen in cell cytoplasm. Glycogen deposits minimally in Col2a1Cre; Idh1 wt/wt control growth plates (n = 8). (G) Quantification of PAS-stained area (μm 2 ), normalized to total number of cells, and PAS-D-stained area (n = 8). (H) GYS1 staining is elevated in Col2a1Cre; Idh1 LSL/wt growth plates compared with Col2a1Cre; Idh1 wt/wt growth plates (n = 5). (I) Quantification of GYS1 staining from hypertrophic to resting zones (n = 5). (J) PYGL staining is unchanged in Col2a1Cre; Idh1 LSL/wt and Col2a1Cre; Idh1 wt/wt growth plates (n = 6). (K) Quantification of PYGL staining from hypertrophic to resting zones (n = 6). (L) Gene expression levels of glycogen genes are elevated upon Idh1 mutation induced by <t>adenovirus</t> Cre <t>recombinase</t> transfection (n = 3). Relative gene expression compared with adenovirus <t>GFP</t> control group was calculated and normalized to β-actin using the 2 −ΔΔCt method. One-way ANOVA with Tukey’s multiple comparisons test = p < 0.05. p value = Student’s t test p < 0.05, an asterisk (*) indicates that significant p values are shown. Means and error bars representing standard deviations are shown. Scale bars: 2 μm in white, 100 μm in black, and 10 μm in blue. Magnification: whole growth plate images: 13× magnification, inset images: 60× magnification.
    Cmv Gfp Adenovirus, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/adenovirus+ad+cmv+gfp/Ad-GFP/pmc07415734-37-0-3
    Average 96 stars, based on 1 article reviews
    cmv gfp adenovirus - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    Vector Biolabs adenovirus other adeno
    (A) Transmission electron microscopy (TEM) images of IDH non-mutant chondrosarcoma cells (n = 4) in vitro display absent glycogen granules. Organelles distinct from glycogen granules shown in magnified insets labeled as follows: M, mitochondria; L, lysosome; ER, rough endoplasmic reticulum. TEM images: 7× magnification, inset images: 70× magnification. (B) TEM images of mutant IDH chondrosarcoma cells (n = 7) display glycogen pools, asterisks denote aggregates of glycogen pools in mutant IDH cells, and arrows in magnified insets indicate glycogen pools. Glycogen appears as closely packed circular granules in mutant IDH chondrosarcoma patient cells. Images: 7× magnification, inset images: 70× magnification. (C) Glycogen quantification from pulverized patient-derived xenograft chondrosarcoma tissues display an elevation of glycogen in mutant IDH1 (n = 17) and IDH2 (n = 8) tumors compared with non-mutant tumors (n = 8). One-way ANOVA confirms significant statistical difference of glycogen levels between tumor genotypes (F(2,30) = 6.150, p = 0.0058). Tukey’s multiple comparisons test indicates that the mean values of glycogen in mutant IDH1 (p = 0.0107) and mutant IDH2 groups (p = 0.0109) were significantly higher than in non-mutant tumors. (D) PAS staining identified glycogen deposits in mutant IDH1 (n = 4) and IDH2 (n = 4) patient chondrosarcomas compared with non-mutant tumors (n = 5). PAS-D staining displays dissolution of glycogen deposits in mutant IDH tumors, thus confirming the presence of glycogen deposits. Arrows in magnified insets indicate glycogen deposits in cytoplasm of cells. Images: 40× magnification, inset images: 60× magnification. (E) Quantification of PAS-stained area (μm 2 ), normalized to total number of cells, and of PAS-D-stained area shows an elevation of glycogen deposits in mutant IDH1 (n = 4) and IDH2 (n = 4) chondrosarcomas compared with non-mutant tumors (n = 5). One-way ANOVA confirms significant statistical difference of glycogen levels between tumor genotypes (F(2,10) = 7.537, p = 0.0101). Tukey’s multiple comparisons test indicates mean values of glycogen in mutant IDH1 (p = 0.0380) and mutant IDH2 groups (p = 0.0123) were significantly higher than non-mutant tumors. (F) Glycogen deposits in Col2a1Cre; Idh1 LSL/wt E18.5 growth plates (n = 9) shown by PAS staining. Arrows in magnified insets indicate glycogen in cell cytoplasm. Glycogen deposits minimally in Col2a1Cre; Idh1 wt/wt control growth plates (n = 8). (G) Quantification of PAS-stained area (μm 2 ), normalized to total number of cells, and PAS-D-stained area (n = 8). (H) GYS1 staining is elevated in Col2a1Cre; Idh1 LSL/wt growth plates compared with Col2a1Cre; Idh1 wt/wt growth plates (n = 5). (I) Quantification of GYS1 staining from hypertrophic to resting zones (n = 5). (J) PYGL staining is unchanged in Col2a1Cre; Idh1 LSL/wt and Col2a1Cre; Idh1 wt/wt growth plates (n = 6). (K) Quantification of PYGL staining from hypertrophic to resting zones (n = 6). (L) Gene expression levels of glycogen genes are elevated upon Idh1 mutation induced by <t>adenovirus</t> Cre <t>recombinase</t> transfection (n = 3). Relative gene expression compared with adenovirus <t>GFP</t> control group was calculated and normalized to β-actin using the 2 −ΔΔCt method. One-way ANOVA with Tukey’s multiple comparisons test = p < 0.05. p value = Student’s t test p < 0.05, an asterisk (*) indicates that significant p values are shown. Means and error bars representing standard deviations are shown. Scale bars: 2 μm in white, 100 μm in black, and 10 μm in blue. Magnification: whole growth plate images: 13× magnification, inset images: 60× magnification.
    Adenovirus Other Adeno, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/adenovirus+ad+cmv+gfp/Ad-CMV-Null/10__7554_slash_elife__60646-387-220-223
    Average 96 stars, based on 1 article reviews
    adenovirus other adeno - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    Image Search Results


    (A) Transmission electron microscopy (TEM) images of IDH non-mutant chondrosarcoma cells (n = 4) in vitro display absent glycogen granules. Organelles distinct from glycogen granules shown in magnified insets labeled as follows: M, mitochondria; L, lysosome; ER, rough endoplasmic reticulum. TEM images: 7× magnification, inset images: 70× magnification. (B) TEM images of mutant IDH chondrosarcoma cells (n = 7) display glycogen pools, asterisks denote aggregates of glycogen pools in mutant IDH cells, and arrows in magnified insets indicate glycogen pools. Glycogen appears as closely packed circular granules in mutant IDH chondrosarcoma patient cells. Images: 7× magnification, inset images: 70× magnification. (C) Glycogen quantification from pulverized patient-derived xenograft chondrosarcoma tissues display an elevation of glycogen in mutant IDH1 (n = 17) and IDH2 (n = 8) tumors compared with non-mutant tumors (n = 8). One-way ANOVA confirms significant statistical difference of glycogen levels between tumor genotypes (F(2,30) = 6.150, p = 0.0058). Tukey’s multiple comparisons test indicates that the mean values of glycogen in mutant IDH1 (p = 0.0107) and mutant IDH2 groups (p = 0.0109) were significantly higher than in non-mutant tumors. (D) PAS staining identified glycogen deposits in mutant IDH1 (n = 4) and IDH2 (n = 4) patient chondrosarcomas compared with non-mutant tumors (n = 5). PAS-D staining displays dissolution of glycogen deposits in mutant IDH tumors, thus confirming the presence of glycogen deposits. Arrows in magnified insets indicate glycogen deposits in cytoplasm of cells. Images: 40× magnification, inset images: 60× magnification. (E) Quantification of PAS-stained area (μm 2 ), normalized to total number of cells, and of PAS-D-stained area shows an elevation of glycogen deposits in mutant IDH1 (n = 4) and IDH2 (n = 4) chondrosarcomas compared with non-mutant tumors (n = 5). One-way ANOVA confirms significant statistical difference of glycogen levels between tumor genotypes (F(2,10) = 7.537, p = 0.0101). Tukey’s multiple comparisons test indicates mean values of glycogen in mutant IDH1 (p = 0.0380) and mutant IDH2 groups (p = 0.0123) were significantly higher than non-mutant tumors. (F) Glycogen deposits in Col2a1Cre; Idh1 LSL/wt E18.5 growth plates (n = 9) shown by PAS staining. Arrows in magnified insets indicate glycogen in cell cytoplasm. Glycogen deposits minimally in Col2a1Cre; Idh1 wt/wt control growth plates (n = 8). (G) Quantification of PAS-stained area (μm 2 ), normalized to total number of cells, and PAS-D-stained area (n = 8). (H) GYS1 staining is elevated in Col2a1Cre; Idh1 LSL/wt growth plates compared with Col2a1Cre; Idh1 wt/wt growth plates (n = 5). (I) Quantification of GYS1 staining from hypertrophic to resting zones (n = 5). (J) PYGL staining is unchanged in Col2a1Cre; Idh1 LSL/wt and Col2a1Cre; Idh1 wt/wt growth plates (n = 6). (K) Quantification of PYGL staining from hypertrophic to resting zones (n = 6). (L) Gene expression levels of glycogen genes are elevated upon Idh1 mutation induced by adenovirus Cre recombinase transfection (n = 3). Relative gene expression compared with adenovirus GFP control group was calculated and normalized to β-actin using the 2 −ΔΔCt method. One-way ANOVA with Tukey’s multiple comparisons test = p < 0.05. p value = Student’s t test p < 0.05, an asterisk (*) indicates that significant p values are shown. Means and error bars representing standard deviations are shown. Scale bars: 2 μm in white, 100 μm in black, and 10 μm in blue. Magnification: whole growth plate images: 13× magnification, inset images: 60× magnification.

    Journal: Cell reports

    Article Title: Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation

    doi: 10.1016/j.celrep.2023.112578

    Figure Lengend Snippet: (A) Transmission electron microscopy (TEM) images of IDH non-mutant chondrosarcoma cells (n = 4) in vitro display absent glycogen granules. Organelles distinct from glycogen granules shown in magnified insets labeled as follows: M, mitochondria; L, lysosome; ER, rough endoplasmic reticulum. TEM images: 7× magnification, inset images: 70× magnification. (B) TEM images of mutant IDH chondrosarcoma cells (n = 7) display glycogen pools, asterisks denote aggregates of glycogen pools in mutant IDH cells, and arrows in magnified insets indicate glycogen pools. Glycogen appears as closely packed circular granules in mutant IDH chondrosarcoma patient cells. Images: 7× magnification, inset images: 70× magnification. (C) Glycogen quantification from pulverized patient-derived xenograft chondrosarcoma tissues display an elevation of glycogen in mutant IDH1 (n = 17) and IDH2 (n = 8) tumors compared with non-mutant tumors (n = 8). One-way ANOVA confirms significant statistical difference of glycogen levels between tumor genotypes (F(2,30) = 6.150, p = 0.0058). Tukey’s multiple comparisons test indicates that the mean values of glycogen in mutant IDH1 (p = 0.0107) and mutant IDH2 groups (p = 0.0109) were significantly higher than in non-mutant tumors. (D) PAS staining identified glycogen deposits in mutant IDH1 (n = 4) and IDH2 (n = 4) patient chondrosarcomas compared with non-mutant tumors (n = 5). PAS-D staining displays dissolution of glycogen deposits in mutant IDH tumors, thus confirming the presence of glycogen deposits. Arrows in magnified insets indicate glycogen deposits in cytoplasm of cells. Images: 40× magnification, inset images: 60× magnification. (E) Quantification of PAS-stained area (μm 2 ), normalized to total number of cells, and of PAS-D-stained area shows an elevation of glycogen deposits in mutant IDH1 (n = 4) and IDH2 (n = 4) chondrosarcomas compared with non-mutant tumors (n = 5). One-way ANOVA confirms significant statistical difference of glycogen levels between tumor genotypes (F(2,10) = 7.537, p = 0.0101). Tukey’s multiple comparisons test indicates mean values of glycogen in mutant IDH1 (p = 0.0380) and mutant IDH2 groups (p = 0.0123) were significantly higher than non-mutant tumors. (F) Glycogen deposits in Col2a1Cre; Idh1 LSL/wt E18.5 growth plates (n = 9) shown by PAS staining. Arrows in magnified insets indicate glycogen in cell cytoplasm. Glycogen deposits minimally in Col2a1Cre; Idh1 wt/wt control growth plates (n = 8). (G) Quantification of PAS-stained area (μm 2 ), normalized to total number of cells, and PAS-D-stained area (n = 8). (H) GYS1 staining is elevated in Col2a1Cre; Idh1 LSL/wt growth plates compared with Col2a1Cre; Idh1 wt/wt growth plates (n = 5). (I) Quantification of GYS1 staining from hypertrophic to resting zones (n = 5). (J) PYGL staining is unchanged in Col2a1Cre; Idh1 LSL/wt and Col2a1Cre; Idh1 wt/wt growth plates (n = 6). (K) Quantification of PYGL staining from hypertrophic to resting zones (n = 6). (L) Gene expression levels of glycogen genes are elevated upon Idh1 mutation induced by adenovirus Cre recombinase transfection (n = 3). Relative gene expression compared with adenovirus GFP control group was calculated and normalized to β-actin using the 2 −ΔΔCt method. One-way ANOVA with Tukey’s multiple comparisons test = p < 0.05. p value = Student’s t test p < 0.05, an asterisk (*) indicates that significant p values are shown. Means and error bars representing standard deviations are shown. Scale bars: 2 μm in white, 100 μm in black, and 10 μm in blue. Magnification: whole growth plate images: 13× magnification, inset images: 60× magnification.

    Article Snippet: Ad-CMV-Cre Cre recombinase adenovirus co-expression with GFP , Vector Biolabs , 1700.

    Techniques: Transmission Assay, Electron Microscopy, Mutagenesis, In Vitro, Labeling, Derivative Assay, Staining, Dissolution, Control, Gene Expression, Transfection

    (A) HIF1⍺ staining is elevated in Col2a1Cre; Idh1 LSL/wt E18.5 growth plates compared with Col2a1Cre; Idh1 wt/wt growth plates (n = 3). Inset images taken at 20× magnification at the proliferative zone of the growth plate. (B) Quantification of HIF1⍺ staining from hypertrophic to resting zones (n = 3). (C) GLUT1 staining is elevated in Col2a1Cre; Idh1 LSL/wt growth plates compared with Col2a1Cre; Idh1 wt/wt growth plates (n = 3). Inset images taken at 20× magnification at the proliferative zone of the growth plate. (D) Quantification of GLUT1 staining from hypertrophic to resting zones (n = 3). (E) Gene expression levels of HIF1⍺ target genes are significantly reduced upon Idh1 mutation and HIF1⍺ knockdown induced by adenovirus Cre recombinase transfection (n = 3). (F) Gene expression levels of glycogen metabolism genes are significantly reduced upon Idh1 mutation and HIF1⍺ knockdown (n = 3). (G) Ex vivo explant cultures of E16.5 Col2a1Cre-ERT; Idh1 LSL/wt metatarsals display reduced glycogen (PAS) and HIF1⍺ levels upon pharmacological blockade of HIF1⍺ by 0.5 μM digoxin treatment for 4 days (n = 6). Inset images are taken at 15× magnification at the central area of the growth plate. p value = Student’s t test p < 0.05, an asterisk (*) indicates that significant p values are shown. Means and error bars representing standard deviations are shown. Scale bars: 100 μm in black, 50 μm in blue, and 20 μm in white.

    Journal: Cell reports

    Article Title: Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation

    doi: 10.1016/j.celrep.2023.112578

    Figure Lengend Snippet: (A) HIF1⍺ staining is elevated in Col2a1Cre; Idh1 LSL/wt E18.5 growth plates compared with Col2a1Cre; Idh1 wt/wt growth plates (n = 3). Inset images taken at 20× magnification at the proliferative zone of the growth plate. (B) Quantification of HIF1⍺ staining from hypertrophic to resting zones (n = 3). (C) GLUT1 staining is elevated in Col2a1Cre; Idh1 LSL/wt growth plates compared with Col2a1Cre; Idh1 wt/wt growth plates (n = 3). Inset images taken at 20× magnification at the proliferative zone of the growth plate. (D) Quantification of GLUT1 staining from hypertrophic to resting zones (n = 3). (E) Gene expression levels of HIF1⍺ target genes are significantly reduced upon Idh1 mutation and HIF1⍺ knockdown induced by adenovirus Cre recombinase transfection (n = 3). (F) Gene expression levels of glycogen metabolism genes are significantly reduced upon Idh1 mutation and HIF1⍺ knockdown (n = 3). (G) Ex vivo explant cultures of E16.5 Col2a1Cre-ERT; Idh1 LSL/wt metatarsals display reduced glycogen (PAS) and HIF1⍺ levels upon pharmacological blockade of HIF1⍺ by 0.5 μM digoxin treatment for 4 days (n = 6). Inset images are taken at 15× magnification at the central area of the growth plate. p value = Student’s t test p < 0.05, an asterisk (*) indicates that significant p values are shown. Means and error bars representing standard deviations are shown. Scale bars: 100 μm in black, 50 μm in blue, and 20 μm in white.

    Article Snippet: Ad-CMV-Cre Cre recombinase adenovirus co-expression with GFP , Vector Biolabs , 1700.

    Techniques: Staining, Gene Expression, Mutagenesis, Knockdown, Transfection, Ex Vivo